secwatch.observer — SEC 8-K summary
======================================

Issuer:     CRESCENT BIOPHARMA, INC. (CBIO)
CIK:        0001253689
Form:       8-K
Filed at:   2022-10-04T23:59:59+00:00
Accession:  0001558370-22-014828
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GlycoMimetics files 8-K with slide presentation for investor meetings; content not disclosed
--------------------------------------------------------------------------------

- Slide presentation furnished as Exhibit 99.1 for investor meetings on October 4, 2022.
- No financial or clinical data from the presentation is included in this filing.
- The presentation is provided under Regulation FD and is not deemed filed for SEC purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022014828/0001558370-22-014828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1253689/000155837022014828/glyc-20221004x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-22-014828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer